Zobrazeno 1 - 10
of 75
pro vyhledávání: '"S V, Khokhlova"'
Publikováno v:
Опухоли женской репродуктивной системы, Vol 20, Iss 2, Pp 74-82 (2024)
This article provides a review of studies analyzing the etiology, diagnosis, and treatment of Peitz–Jeghers syndrome, as well as the risk of cancer of different locations in patients with this genetic disorder. We report a case of Peitz–Jeghers s
Externí odkaz:
https://doaj.org/article/69f13b810bb4428983d564902c563e51
Autor:
T. M. Zavarykina, P. K. Lomskova, M. A. Kapralova, O. O. Gordeeva, I. P. Ganshina, D. S. Khodyrev, S. V. Khokhlova, I. V. Kolyadina
Publikováno v:
Опухоли женской репродуктивной системы, Vol 18, Iss 4, Pp 69-80 (2023)
Background. Breast cancer is the most common cancer among women. Triple negative breast cancer (TNBC) is the most aggressive subtype of breast cancer, in which there are no special targets for therapy. Therefore chemotherapy is still leading treatmen
Externí odkaz:
https://doaj.org/article/5ed10ee33c6541e192682c3fd761a34a
Autor:
D. A. Morozov, I. V. Kolyadina, I. V. Poddubnaya, I. P. Ganshina, S. V. Khokhlova, V. V. Kometova, V. V. Rodionov
Publikováno v:
Опухоли женской репродуктивной системы, Vol 17, Iss 4, Pp 38-47 (2022)
Background. The role of neoadjuvant chemotherapy (NACT) in luminal HER2-negative breast cancer (BC) remains highly controversial due to the lack of reliable predictors of drug therapy efficacy.Objective: to evaluate the effectiveness of NACT in patie
Externí odkaz:
https://doaj.org/article/48891bdc57a34ef6aade197e0a894a47
Publikováno v:
Опухоли женской репродуктивной системы, Vol 17, Iss 3, Pp 97-105 (2021)
Background. According to randomized clinical trial SOLO1 olaparib statistically significantly improves progression-free survival versus placebo as a maintenance monotherapy in patients aged 18 and over with newly diagnosed advanced ovarian cancer wit
Externí odkaz:
https://doaj.org/article/541e4bf2e7d3463b9713e0cb8c3f38ba
Publikováno v:
Современная онкология, Vol 22, Iss 3, Pp 154-159 (2020)
Young women with reproductive tract neoplasms who receive treatment leading to termination of ovarian function often suffer from menopause symptoms that contribute to dramatic drop in quality of life. Climacteric symptoms in women with iatrogenic men
Externí odkaz:
https://doaj.org/article/52b9e89766084baa8bff62d4d69a125b
Publikováno v:
Опухоли женской репродуктивной системы, Vol 16, Iss 2, Pp 38-43 (2020)
Breast angiosarcoma (BAS) is an extremely rare and poorly studied neoplasm, the etiology of primary BAS remains controversial, and secondary BAS is most often radio-induced. Radio-induced breast tumors usually appear 10–20 years after the initial t
Externí odkaz:
https://doaj.org/article/cd5dbe340fce4c6dae2e2caaddb84d99
Autor:
S. V. Khokhlova
Publikováno v:
Медицинский совет, Vol 0, Iss 9, Pp 128-135 (2020)
In 2011, a standard approach to the treatment of primary ovarian cancer (OC) included a cytoreductive surgery, which could be performed after 2–3 cycles of neoadjuvant chemotherapy, and chemotherapy consisting of platinum and taxanes. Such approach
Externí odkaz:
https://doaj.org/article/55dc4a735de840eaa5912c8afd4d6bd6
Autor:
S. V. Khokhlova
Publikováno v:
Медицинский совет, Vol 0, Iss 19, Pp 150-156 (2019)
Ovarian cancer is the fifth leading cause of cancer-related death among women in the world. In spite of recent progress in treatment strategy, around 70 % of ovarian cancer patients relapse. The cytoreductive surgery followed by platinum-, taxane-con
Externí odkaz:
https://doaj.org/article/5fac508d390a49a884aeff3dbeeb4832
Publikováno v:
Сибирский онкологический журнал, Vol 17, Iss 1, Pp 55-63 (2018)
More than 300 000 new cases of endometrial cancer (EC) are registered annually in the world. The prognosis for EC is determined by the stage of the disease. In Russia, stage III–IV EC is diagnosed in 16 % of patients, with the mortality rate in the
Externí odkaz:
https://doaj.org/article/b11fedfe4d6d45989a5edf48aa21d20a
Autor:
Ya. Z. Plieva, V. D. Ermilova, I. V. Tereshkina, D. N. Kushlinskiy, V. M. Shelepova, D. O. Utkin, S. V. Khokhlova, E. K. Dvorova, Yu. G. Payanidi, K. I. Zhordania
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 45, Iss 8, Pp 616-627 (2018)
Aim: To perform a comparative analysis with simultaneous measurement of vascular endothelial growth factor (VEGF), insulin-like growth factor 1 (IGF1) and matrix metalloproteinase 7 (MMP7) in serum samples taken from healthy women and ovarian cancer
Externí odkaz:
https://doaj.org/article/c5640995afbc4e0d937e85263b1541f3